This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

Concomitant Use of SPRAVATO with COVID-19 Vaccines

Last Updated: 02/08/2024

SUMMARY  

  • Use with COVID-19 Vaccines
    • Currently, there are no published studies on the concomitant use of COVID-19 vaccines and SPRAVATO.
    • Clinicians should use clinical judgement based on local/institutional guidelines, standards of care, and individual patient risk/benefit assessment when considering concomitant use of SPRAVATO and COVID-19 vaccines.
    • For additional information regarding the use of COVID-19 vaccines, please contact the vaccine manufacturer.
  • General Vaccination Information

Literature Search

A literature search of MEDLINE®, Embase®, BIOSIS Previews®, and Derwent Drug File (and/or other resources, including internal/external databases) was conducted on
26 December 2023.

 

References

1 Centers for Disease Control and Prevention (CDC). COVID-19 ACIP vaccine recommendations. Centers for Disease Control and Prevention (CDC); 2020. Accessed January 16, 2024.